205 related articles for article (PubMed ID: 29189762)
21. Antituberculosis agents. VII. Synthesis and in vitro evaluation of antimycobacterial activity and cytotoxicity of some N-piperazinyl quinolone derivatives.
Foroumadi A; Soltani F; Asadipour A
Boll Chim Farm; 2003 Apr; 142(3):130-4. PubMed ID: 12806833
[TBL] [Abstract][Full Text] [Related]
22. Synthesis and antimycobacterial activity of novel camphane-based agents.
Stavrakov G; Philipova I; Valcheva V; Momekov G
Bioorg Med Chem Lett; 2014 Jan; 24(1):165-7. PubMed ID: 24332625
[TBL] [Abstract][Full Text] [Related]
23. Synthesis and antitubercular evaluation of 4-carbonyl piperazine substituted 1,3-benzothiazin-4-one derivatives.
Peng CT; Gao C; Wang NY; You XY; Zhang LD; Zhu YX; Xv Y; Zuo WQ; Ran K; Deng HX; Lei Q; Xiao KJ; Yu LT
Bioorg Med Chem Lett; 2015 Apr; 25(7):1373-6. PubMed ID: 25754492
[TBL] [Abstract][Full Text] [Related]
24. Antitubercular activity of quinolizidinyl/pyrrolizidinylalkyliminophenazines.
Tonelli M; Novelli F; Tasso B; Sparatore A; Boido V; Sparatore F; Cannas S; Molicotti P; Zanetti S; Parapini S; Loddo R
Bioorg Med Chem; 2014 Dec; 22(24):6837-45. PubMed ID: 25464882
[TBL] [Abstract][Full Text] [Related]
25. Synthesis, characterization of novel coupling products and 4-arylhydrazono-2-pyrazoline-5-ones as potential antimycobacterial agents.
Küçükgüzel SG; Rollas S
Farmaco; 2002 Jul; 57(7):583-7. PubMed ID: 12164219
[TBL] [Abstract][Full Text] [Related]
26. The oriented development of antituberculotics: salicylanilides.
Waisser K; Matyk J; Divisová H; Husáková P; Kunes J; Klimesová V; Kaustová J; Möllmann U; Dahse HM; Miko M
Arch Pharm (Weinheim); 2006 Nov; 339(11):616-20. PubMed ID: 17048291
[TBL] [Abstract][Full Text] [Related]
27. Thienopyrimidines as novel inhibitors of Mycobacterium tuberculosis: synthesis and in-vitro studies.
Rashmi P; Nargund LV; Hazra K; Chandra JN
Arch Pharm (Weinheim); 2011 Jul; 344(7):459-65. PubMed ID: 21598298
[TBL] [Abstract][Full Text] [Related]
28. Antimycobacterial activity of novel 1-(5-cyclobutyl-1,3-oxazol-2-yl)-3-(sub)phenyl/pyridylthiourea compounds endowed with high activity toward multidrug-resistant Mycobacterium tuberculosis.
Sriram D; Yogeeswari P; Dinakaran M; Thirumurugan R
J Antimicrob Chemother; 2007 Jun; 59(6):1194-6. PubMed ID: 17449482
[TBL] [Abstract][Full Text] [Related]
29. On the relationship between the substitution pattern of thiobenzanilides and their antimycobacterial activity.
Kunes J; Balsánek V; Pour M; Waisser K; Kaustová J
Farmaco; 2002 Sep; 57(9):777-82. PubMed ID: 12385530
[TBL] [Abstract][Full Text] [Related]
30. [In vitro antimycobacterial activity of a new quinolone, NM394].
Tomioka H; Sato K; Saito H
Kekkaku; 1993 Aug; 68(8):517-20. PubMed ID: 8397311
[TBL] [Abstract][Full Text] [Related]
31. 1-Substituted-5-[(3,5-dinitrobenzyl)sulfanyl]-1H-tetrazoles and their isosteric analogs: A new class of selective antitubercular agents active against drug-susceptible and multidrug-resistant mycobacteria.
Karabanovich G; Roh J; Smutný T; Němeček J; Vicherek P; Stolaříková J; Vejsová M; Dufková I; Vávrová K; Pávek P; Klimešová V; Hrabálek A
Eur J Med Chem; 2014 Jul; 82():324-40. PubMed ID: 24927053
[TBL] [Abstract][Full Text] [Related]
32. Identification of new diamine scaffolds with activity against Mycobacterium tuberculosis.
Bogatcheva E; Hanrahan C; Nikonenko B; Samala R; Chen P; Gearhart J; Barbosa F; Einck L; Nacy CA; Protopopova M
J Med Chem; 2006 Jun; 49(11):3045-8. PubMed ID: 16722620
[TBL] [Abstract][Full Text] [Related]
33. Highly active antimycobacterial derivatives of benzoxazine.
Petrlíková E; Waisser K; Divišová H; Husáková P; Vrabcová P; Kuneš J; Kolář K; Stolaříková J
Bioorg Med Chem; 2010 Dec; 18(23):8178-87. PubMed ID: 21044844
[TBL] [Abstract][Full Text] [Related]
34. 5-Alkylamino-
Ambrożkiewicz W; Kučerová-Chlupáčová M; Janďourek O; Konečná K; Paterová P; Bárta P; Vinšová J; Doležal M; Zitko J
Molecules; 2020 Mar; 25(7):. PubMed ID: 32231166
[TBL] [Abstract][Full Text] [Related]
35. Discovery of novel 5-(ethyl or hydroxymethyl) analogs of 2'-'up' fluoro (or hydroxyl) pyrimidine nucleosides as a new class of Mycobacterium tuberculosis, Mycobacterium bovis and Mycobacterium avium inhibitors.
Shakya N; Srivastav NC; Bhavanam S; Tse C; Desroches N; Agrawal B; Kunimoto DY; Kumar R
Bioorg Med Chem; 2012 Jul; 20(13):4088-97. PubMed ID: 22664188
[TBL] [Abstract][Full Text] [Related]
36. New lipophilic isoniazid derivatives and their 1,3,4-oxadiazole analogues: Synthesis, antimycobacterial activity and investigation of their mechanism of action.
Vosátka R; Krátký M; Švarcová M; Janoušek J; Stolaříková J; Madacki J; Huszár S; Mikušová K; Korduláková J; Trejtnar F; Vinšová J
Eur J Med Chem; 2018 May; 151():824-835. PubMed ID: 29679902
[TBL] [Abstract][Full Text] [Related]
37. Synthesis, antitubercular activity, and SAR study of N-substituted-phenylamino-5-methyl-1H-1,2,3-triazole-4-carbohydrazides.
Jordão AK; Sathler PC; Ferreira VF; Campos VR; de Souza MC; Castro HC; Lannes A; Lourenco A; Rodrigues CR; Bello ML; Lourenco MC; Carvalho GS; Almeida MC; Cunha AC
Bioorg Med Chem; 2011 Sep; 19(18):5605-11. PubMed ID: 21840219
[TBL] [Abstract][Full Text] [Related]
38. Synthesis of pyrazinamide Mannich bases and its antitubercular properties.
Sriram D; Yogeeswari P; Reddy SP
Bioorg Med Chem Lett; 2006 Apr; 16(8):2113-6. PubMed ID: 16464574
[TBL] [Abstract][Full Text] [Related]
39. Synthesis of 1-[3-(4-benzotriazol-1/2-yl-3-fluoro-phenyl)-2-oxo-oxazolidin-5-ylmethyl]-3-substituted-thiourea derivatives as antituberculosis agents.
Dixit PP; Patil VJ; Nair PS; Jain S; Sinha N; Arora SK
Eur J Med Chem; 2006 Mar; 41(3):423-8. PubMed ID: 16494970
[TBL] [Abstract][Full Text] [Related]
40. Synthesis, antibacterial and antimycobacterial activities of some new 4-aryl/heteroaryl-2,6-dimethyl-3,5-bis-N-(aryl)-carbamoyl-1,4-dihydropyridines.
Sirisha K; Bikshapathi D; Achaiah G; Reddy VM
Eur J Med Chem; 2011 May; 46(5):1564-71. PubMed ID: 21382653
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]